Answers are grounded in this paper and cite their sources.
SUMMARY The use of erythrocyte transfusions to treat anemia in neonatal and pediatric surgery patients has changed dramatically over the last decade. Recombinant human erythropoietin (rHuEPO) has been shown to decrease transfusion exposure in many disease states in both adults and children. rHuEPO has also been used perioperatively in children. This paper discusses perioperative anemia, the current status of rHuEPO therapy, surgical and non‐surgical strategies that minimize blood loss, and transfusion therapy in the pediatric surgical patient.
No takes yet. Share an insight, caveat, or question.
Pamela J. Kling (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: